AHA files motions as 340B case returns to district court to determine remedy

Aug 04, 2022 - 03:10 PM
340B-update-900x400

Following its unanimous victory in the U.S. Supreme Court earlier this summer, AHA yesterday asked the U.S. District Court for the District of Columbia to order the Department of Health and Human Services to immediately stop underpaying certain hospitals that participate in the 340B Drug Pricing Program and promptly repay them for the unlawful cuts since 2018 without penalizing other hospitals.

Related News Articles

Headline
AHA comments on the SUSTAIN 340B Act
The AHA Oct. 27 submitted comments on the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B…
Headline
AHA urges court to reject drug industry intervention in 340B rebate program case
The U.S. District Court for the District of Maine should deny motions by several drug companies and Pharmaceutical Research and Manufacturers of America to…
Headline
AHA expresses support for House bill that would delay 340B rebate model
The AHA today voiced support () for the 340B Rebate Model Delay Act (H.R. 10770)in a letter to the bill’s House sponsors. The bipartisan bill would pause the…
Headline
AHA, others file suit to stop costly 340B rebate program from harming hospitals and patients 
The AHA, the Maine Hospital Association and four safety-net hospitals Oct. 9 filed a lawsuit in the U.S. District Court for the District of Maine challenging…
Headline
AHA, others file amicus brief supporting hospital in challenge to Lilly 340B policy
The AHA, the New Hampshire Hospital Association and 340B Health have filed an amicus brief supporting Mary Hitchcock Memorial Hospital’s request for a…
Headline
HRSA approves 10 drug companies for participation in the 340B Rebate Model Pilot Program
The Department of Health and Human Services’ Health Resources and Services Administration Oct. 1 announced approval of 10 drug companies to participate in the…